clofibrate and acipimox

clofibrate has been researched along with acipimox in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (66.67)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Demacker, PN; Stalenhoef, AF; Stuyt, PM; Van 't Laar, A	1
Branzoli, U; Chiari, A; Lovisolo, PP; Orsini, G	1

Trials

1 trial(s) available for clofibrate and acipimox

Article	Year
A comparative study of the effects of acipimox and clofibrate in type III and type IV hyperlipoproteinemia. Atherosclerosis, 1985, Volume: 55, Issue:1 Topics: Adult; Aged; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins A; Apolipoproteins B; Cholesterol; Clofibrate; Female; Humans; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Lipase; Lipoprotein Lipase; Lipoproteins; Male; Middle Aged; Pyrazines; Triglycerides	1985

Article

Year

A comparative study of the effects of acipimox and clofibrate in type III and type IV hyperlipoproteinemia.

Atherosclerosis, 1985, Volume: 55, Issue:1

Topics: Adult; Aged; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins A; Apolipoproteins B; Cholesterol; Clofibrate; Female; Humans; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Lipase; Lipoprotein Lipase; Lipoproteins; Male; Middle Aged; Pyrazines; Triglycerides

1985

Other Studies

2 other study(ies) available for clofibrate and acipimox

Article	Year
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Effect of the antilipolytic compound acipimox on peroxisome marker enzymes, lipid pattern and biotransformation related functions in rat liver. Pharmacological research communications, 1985, Volume: 17, Issue:10 Topics: Animals; Biotransformation; Clofibrate; Cytochrome P-450 Enzyme System; Enzymes; Glutathione; Hypolipidemic Agents; Lipid Metabolism; Liver; Male; Microbodies; Molecular Weight; Proteins; Pyrazines; Rats	1985

Article

Year

A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.

Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013

Effect of the antilipolytic compound acipimox on peroxisome marker enzymes, lipid pattern and biotransformation related functions in rat liver.

Pharmacological research communications, 1985, Volume: 17, Issue:10

Topics: Animals; Biotransformation; Clofibrate; Cytochrome P-450 Enzyme System; Enzymes; Glutathione; Hypolipidemic Agents; Lipid Metabolism; Liver; Male; Microbodies; Molecular Weight; Proteins; Pyrazines; Rats

1985